Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
11 | 119212608 | intron variant | A/C | snv | 0.27 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
1.000 | 11 | 119278170 | missense variant | A/C;G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
1.000 | 11 | 119278170 | missense variant | A/C;G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.827 | 0.080 | 11 | 119278182 | missense variant | A/C;G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.827 | 0.080 | 11 | 119278182 | missense variant | A/C;G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.827 | 0.080 | 11 | 119278182 | missense variant | A/C;G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.710 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
1.000 | 11 | 119278170 | missense variant | A/C;G | snv |
|
0.800 | 0 | |||||||||||||
|
0.827 | 0.080 | 11 | 119278182 | missense variant | A/C;G | snv |
|
0.700 | 0 | ||||||||||||
|
0.827 | 0.080 | 11 | 119278182 | missense variant | A/C;G | snv |
|
0.700 | 0 | ||||||||||||
|
0.882 | 0.320 | 11 | 119278508 | splice acceptor variant | A/G | snv |
|
Neoplasms; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 4 | 2009 | 2012 | ||||||||
|
0.882 | 0.320 | 11 | 119278508 | splice acceptor variant | A/G | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 4 | 2009 | 2012 | ||||||||
|
1.000 | 0.040 | 11 | 119301826 | 3 prime UTR variant | A/G | snv | 0.24 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 11 | 119208283 | intron variant | A/G | snv | 0.23 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 11 | 119274564 | intron variant | A/G | snv | 0.27 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.040 | 11 | 119278214 | missense variant | A/G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
1.000 | 0.040 | 11 | 119237017 | intron variant | A/G | snv | 0.59 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 11 | 119237402 | intron variant | A/G | snv | 0.33 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.040 | 11 | 119278214 | missense variant | A/G | snv |
|
0.800 | 0 | ||||||||||||
|
0.882 | 0.320 | 11 | 119278508 | splice acceptor variant | A/G | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
0.851 | 0.320 | 11 | 119278162 | splice acceptor variant | AAAG/- | del |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.851 | 0.320 | 11 | 119278162 | splice acceptor variant | AAAG/- | del |
|
0.700 | 0 | ||||||||||||
|
0.851 | 0.320 | 11 | 119278162 | splice acceptor variant | AAAG/- | del |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 0.700 | 0 | |||||||||||
|
0.851 | 0.320 | 11 | 119278162 | splice acceptor variant | AAAG/- | del |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 0.700 | 0 | |||||||||||
|
0.851 | 0.320 | 11 | 119278162 | splice acceptor variant | AAAG/- | del |
|
0.700 | 0 | ||||||||||||
|
0.851 | 0.320 | 11 | 119278162 | splice acceptor variant | AAAG/- | del |
|
0.700 | 0 |